Heptares Therapeutics
Latest round
- Series B
Last raised
- Jun 2013
Total raised
- $70M
Investors
- 5
About Heptares Therapeutics
Heptares Therapeutics Ltd specializes in drug discovery and development, utilizing its unique expertise in structure-based drug design to create innovative therapies. Founded in 2007, the company is headquartered in Welwyn Garden City, UK., Ltd. for USD 400 mn, marking a significant milestone in its operational strategy.Heptares Therapeutics develops innovative pharmaceuticals aimed at addressing unmet medical needs using advanced structure-based drug design.23 mn., Ltd. to expand its product pipeline and enhance its market presence. The company is focusing on developing new pharmaceuticals that are currently in the design phase, with plans to launch these products in the coming years. Additionally, Heptares intends to expand into new geographic markets, targeting growth in regions that align with its therapeutic focus. The strategic use of the USD 400 mn from the trade sale will support these initiatives, facilitating research and development efforts and establishing new partnerships.
Who invested in Heptares Therapeutics
5 investors across 5 rounds
See all investors in Heptares Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Heptares Therapeutics
Who invested in Heptares Therapeutics?
Heptares Therapeutics has 5 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Heptares Therapeutics raised?
Heptares Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Heptares Therapeutics last raise money?
Heptares Therapeutics's most recent round on record is a Series B, in Jun 2013.
What does Heptares Therapeutics do?
Heptares Therapeutics Ltd specializes in drug discovery and development, utilizing its unique expertise in structure-based drug design to create innovative therapies.
Where is Heptares Therapeutics headquartered?
Heptares Therapeutics is headquartered in Welwyn Garden City, UK.
Which VCs invest in companies like Heptares Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Heptares Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Heptares Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.